Substance P- and Insulin-like Growth Factor 1-derived Tetrap…
Emerging
1
Citations19
Refs2024
Year
Search Works
Work Details
- DOI 10.1016/j.xops.2024.100634
- PMID https://pubmed.ncbi.nlm.nih.gov/39717761
- OpenAlex ID W4403599766
- Type Article
- Language EN
- Published 21 Oct 2024
- Volume 5 (2)
- Pages 100634
- Source Ophthalmology Science
- Publisher Elsevier BV
- FWCI 0.32
- Countries 1
- Institutions 5
- Added 10 Oct 2025
- Updated 26 Sep 2026
External Links
MENU
0
Substance P- and Insulin-like Growth Factor 1-derived Tetrapeptides for Neurotrophic Keratopathy Related to Leprosy: A Clinical Trial
Article 2024 EN Gold
Neurotrophic keratopathy is part of the leprosy sequelae and causes progressive deterioration of visual acuity. Although leprosy is bacteriologically curable, there is currently no efficient treatment. Eye drops containing tetrapeptides, phenylalanine-glycine-leucine-methionine-amide (FGLM-NH 2 ) and serine-serine-serine-arginine (SSSR), derived from substance P and insulin-like growth factor 1, a…
1
Citations
19
References
4
Authors
0.32
FWCI
Citations by Year
Last 1 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
4 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Shoko Kondo Corresponding | National Sanatorium Kikuchi Ke… (JP) | — |
| 2 | Yoshiko Okano | National Sanatorium Ooshima Se… (JP) | — |
| 3 | Satoshi Iraha | National Sanatorium Kikuchi Ke… (JP) Kumamoto University (JP) | |
| 4 | Shoji Tokunaga | Kyushu University (JP) Kyushu University Hospital (JP) |
Related Works
10Data: OpenAlex